CLPB p.Arg573Ser
c.1717C>A · VCV4750700
Computational evidence
| Protein change | ||
| AlphaMissense | 0.4458 | ambiguous |
|---|---|---|
| REVEL | 0.115 | moderately benign-leaning |
| SaProt | LLR -3.77 | tolerated |
| ⇒ REVEL and SaProt both call this tolerated; AlphaMissense makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 2,250 bp · p 0.067 · regional, not allelic |
| Overall | ||
| CADD | 25.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R603S vs ClinVar R573S) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,506 |
| European (non-Finnish)grpmax | 0.000847% | 118,002 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CLPB
- Protein
- p.Arg573Ser
- Coding
- c.1717C>A
- MANE Select
- NM_001258392
- Type
- single nucleotide variant
- Location
- chr11:72294090 (GRCh38)
- Gene constraint
- LOEUF 0.643 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 72.52 · 7 PDB
- Residue 573
- an α-helix
Disease context
3-methylglutaconic aciduria, type VIIB — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor 3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Antenatal, Neonatal
Similar variants
- CLPB p.Arg573His Uncertain significance ★★ ⚠ same residue
- CLPB p.Arg573Cys Uncertain significance ★ ⚠ same residue
- CLPB p.Arg573Pro Uncertain significance ★ ⚠ same residue
- CLPB c.1066+1G>A Pathogenic/Likely pathogenic ★★ same condition
- CLPB c.455+1G>A Likely pathogenic ★★ same condition
- CLPB c.873+1G>A Pathogenic/Likely pathogenic ★★ same condition
- CLPB c.874-2A>G Likely pathogenic ★★ same condition
- CLPB p.Arg178Ter Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/clpb-p-arg573ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown